Guobang Pharmaceutical announced that Zhejiang Guobang, a wholly-owned subsidiary of the company, and florellana, was approved as a Class II new veterinary drug by the Ministry of Agriculture and Rural Affairs, and obtained the “New Veterinary Drug Registration Certificate” on September 28, 2026. The certificate number is New Veterinary Drug Certificate No. 116, and the monitoring period is 4 years. A veterinary drug product approval number is still required before the product is marketed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.